6533b825fe1ef96bd12828e1
RESEARCH PRODUCT
Towards personalized screening for hepatocellular carcinoma: Still not there
Vincenza CalvarusoJordi Bruixsubject
Oncologymedicine.medical_specialtyCarcinoma HepatocellularHepatologybusiness.industryLiver CirrhosiMEDLINEHepatitis Cmedicine.diseaseHepatitis CMachine LearningLiver Neoplasms.Text miningHepatocellular carcinomaInternal medicinemedicinebusinessHumandescription
In patients with HCV-related cirrhosis the annual risk of hepatocellular carcinoma (HCC) is 2–4%.1 However, with the advent of highly effective and well tolerated direct-acting antivirals...
year | journal | country | edition | language |
---|---|---|---|---|
2020-12-01 | Journal of Hepatology |